Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Aug. 01, 2020
Aug. 03, 2019
OPERATING ACTIVITIES:    
Net loss $ (5,774) $ (31,167)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 10,745 6,140
Share-based payment compensation 723 1,257
Amortization of deferred financing costs 98 104
Payments for television distribution rights (1,196) 0
Inventory impairment write-down 0 6,050
Changes in operating assets and liabilities:    
Accounts receivable, net 5,457 11,494
Inventories 17,236 (3,187)
Deferred revenue 73 (17)
Prepaid expenses and other 1,684 (163)
Accounts payable and accrued liabilities (7,773) 9,581
Net cash provided by operating activities 21,273 92
INVESTING ACTIVITIES:    
Property and equipment additions (2,527) (3,491)
Net cash used for investing activities (2,527) (3,491)
FINANCING ACTIVITIES:    
Proceeds from issuance of revolving loan 5,900 109,700
Proceeds from issuance of common stock and warrants 4,000 6,000
Payments on revolving loan (18,800) (109,700)
Payments on term loan (1,357) (1,357)
Payments on finance leases (49) (23)
Payments for common stock issuance costs (17) (66)
Payments for restricted stock issuance (7) (21)
Net cash (used for) provided by financing activities (10,330) 4,533
Net increase in cash and restricted cash equivalents 8,416 1,134
BEGINNING CASH AND RESTRICTED CASH EQUIVALENTS 10,287 20,935
ENDING CASH AND RESTRICTED CASH EQUIVALENTS 18,703 22,069
SUPPLEMENTAL CASH FLOW INFORMATION:    
Interest paid 2,214 1,451
Income taxes paid 80 28
Television distribution rights obtained in exchange for liabilities 30,633 0
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Property and equipment purchases included in accounts payable 302 124
Common stock issuance costs included in accrued liabilities 173 110
Equipment acquired through finance lease obligations 34 188
Issuance of warrants $ 0 $ 193